E-mail Print PDF


Sveinbj-Profile-1-150x150Sveinbjörn Gizurarson, Chairman

Dr. Gizurarson has an extensive research and business experience in the development of nasal drug and vaccine delivery systems. In 1991, Dr. Gizurarson founded Lyfjaþróun Biopharmaceuticals together with Mr. Gudmundur Hallgrimsson and Mr. Steinar S. Waage. Lyfjaþróun was a specialized nasal drug delivery company that initially focused on the safe and non-invasive nasal delivery of antigens and later focused on the delivery of rapid-onset nasal products. Dr. Gizurarson served as Lyfjaþóun’s CEO between 1999 and 2005.

Dr. Gizurarson’s research is widely published, and he has served on journal editorial boards as well as on international government and academic bodies handling issues related to life sciences. Currently he is a professor of pharmaceutics and clinical pharmacokinetics and pharmacodynamics at the University of Iceland. Dr. Gizurarson has served on the Faculty since 1991, after receiving his Ph.D. from University of Copenhagen (The Danish University of Pharmaceutical Sciences) and postdoc position at the National Insitutes of Health of Tokyo in Japan.


Kristin Linda Ragnarsdóttir, CEO


Þú ert hér: Home The Firm People

Support center

Hananja plc

  • Address: Aflagrandi 7
  • City: 107 Reykjavík, Iceland
  • Tel: (+354) 898-0318
  • Email: sg@hananja.com